These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market CLOs may seem intimidating to retail investors, but these ETFs make these complex debt products accessible while helping to boost diversification.
Is Pfizer Stock a "Value Trap" or a Generational Opportunity? Pfizer is an over-100-year-old drug company going through a rough patch, which has happened before.
3 Reasons to Buy Cameco Stock Like There's No Tomorrow The stock's taking a breather after a recent rally, but the company's bright future is likely to manifest sooner rather than later.
A Progyny (PGNY) Insider Sold 5,500 Shares for $137,000 Progyny delivers fertility benefits to major employers; a key insider recently trimmed their stake, according to SEC filings.
3 Monster Dividend Stocks to Buy in June (1 Yields an Eye-Popping 11.2%!) These ultra-high-yielding dividend stocks have done a solid job delivering sustainable income streams.
Interested in Humanoid Robot Stocks? You Might Consider Buying This Humanoid Robotics ETF This humanoid robotics ETF (KOID) has been performing wonderfully, though it's only been in existence for about a year.
3 Things Long-Term Investors Should Do As June Arrives The start of a new month provides the perfect opportunity to take a fresh look at your portfolio.
3 Ways to Play the Data Center Land Grab REITs owning and operating data centers stand to benefit tremendously from fast-growing AI demand, and Equinix and Digital Realty Trust are at the top.
Xometry's (XMTR) CEO Recently Sold 50K Shares. Should You Follow? This digital manufacturing platform, serving diverse industries, reported a notable insider sale amid strong one-year stock performance.
Peleton's (PTON) Chief Commercial Officer Sold All Their Shares for $584,000 Peloton, a leader in connected fitness and digital subscriptions, reported a notable insider sale amid ongoing market challenges.
An Oruka Therapeutics (ORKA) Insider Sold 105,000 Shares Worth $6.2 Million This clinical-stage biotech focused on antibody therapies for immunological disorders reported a notable insider sale in its latest filing.
Franklin Electric's (FELE) President Sold 1,900 Shares. Should You Follow His Lead? This global pumping systems provider operates across key infrastructure markets; a recent insider sale highlights evolving ownership trends.
Velan Capital Drops 140,000 Mineralys Therapeutics (MLYS) Shares Worth $4.1 Million Mineralys Therapeutics develops novel therapies for resistant hypertension, with its lead candidate advancing through clinical trials.
China's AI Dream Fades as Alibaba, Tencent, PDD Plunge While US Stocks Soar China is lagging the US badly in the AI race as top stocks like Alibaba, Tencent, and PDD Holdings plunge amid US stocks surge
What a Comfortable Retirement Actually Costs in California in 2026 The Golden State is beautiful year-round. Living there, however, isn't cheap.
The Smarter Way to Invest in AI Without Taking Extreme Risk Retail investors already have AI exposure through index funds. Learn how to build a smarter AI investing strategy with stocks and ETFs
